The present disclosure provides novel compounds with activity as PPARβ/δ and PPARγ dual agonists. The disclosure also provides methods of treating diabetes mellitus and methods of treating Alzheimers disease utilizing the novel compounds, as well as pharmaceutical formulations comprising the novel compounds.